ATE394503T1 - Pathogene determinanten als zielmoleküle zur entwicklung von mitteln welche bakterielle infektionen und/oder systemische verbreitung verhindern und kontrollieren können - Google Patents

Pathogene determinanten als zielmoleküle zur entwicklung von mitteln welche bakterielle infektionen und/oder systemische verbreitung verhindern und kontrollieren können

Info

Publication number
ATE394503T1
ATE394503T1 AT03762684T AT03762684T ATE394503T1 AT E394503 T1 ATE394503 T1 AT E394503T1 AT 03762684 T AT03762684 T AT 03762684T AT 03762684 T AT03762684 T AT 03762684T AT E394503 T1 ATE394503 T1 AT E394503T1
Authority
AT
Austria
Prior art keywords
prevent
target molecules
bacterial infections
developing agents
serum
Prior art date
Application number
AT03762684T
Other languages
English (en)
Inventor
Sonia Escaich
Original Assignee
Mutabilis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mutabilis filed Critical Mutabilis
Application granted granted Critical
Publication of ATE394503T1 publication Critical patent/ATE394503T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT03762684T 2002-07-09 2003-07-09 Pathogene determinanten als zielmoleküle zur entwicklung von mitteln welche bakterielle infektionen und/oder systemische verbreitung verhindern und kontrollieren können ATE394503T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0208636A FR2842210B1 (fr) 2002-07-09 2002-07-09 Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique

Publications (1)

Publication Number Publication Date
ATE394503T1 true ATE394503T1 (de) 2008-05-15

Family

ID=29763685

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03762684T ATE394503T1 (de) 2002-07-09 2003-07-09 Pathogene determinanten als zielmoleküle zur entwicklung von mitteln welche bakterielle infektionen und/oder systemische verbreitung verhindern und kontrollieren können

Country Status (11)

Country Link
US (3) US20060003393A1 (de)
EP (1) EP1523572B1 (de)
JP (1) JP2006515155A (de)
AT (1) ATE394503T1 (de)
AU (2) AU2003266246A1 (de)
CA (1) CA2491847A1 (de)
DE (1) DE60320797D1 (de)
DK (1) DK1523572T3 (de)
ES (1) ES2306891T3 (de)
FR (1) FR2842210B1 (de)
WO (1) WO2004005535A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842210B1 (fr) * 2002-07-09 2012-12-14 Mutabilis Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique
AU2003298770A1 (en) * 2002-12-02 2004-06-23 Biosynexus Inc Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
SG160329A1 (en) * 2005-02-18 2010-04-29 Novartis Vaccines & Diagnostic Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
DK1858919T3 (da) 2005-02-18 2012-07-16 Novartis Vaccines & Diagnostic Immunogener fra uropathogen Escherichia coli
EP1973467B1 (de) * 2006-01-20 2013-10-16 The General Hospital Corporation Systeme und Verfahren zur Bereitstellung von Speckle-Reduktion über eine Wellenfront -Modulation zur optischen Kohärenzentomographie
EP2064230A2 (de) 2006-08-16 2009-06-03 Novartis AG Immungene aus uropathogenen escherichia coli
HRP20141270T1 (xx) 2009-07-16 2015-03-13 Novartis Ag Detoksificirani imunogeni escherichie coli
CA3021760A1 (en) * 2016-04-25 2017-11-02 Aperture Bio, LLC Systems, devices and methods for sequential analysis of complex matrix samples for high confidence bacterial detection and drug susceptibility prediction using a flow cytometer
JP7515092B2 (ja) * 2017-10-18 2024-07-12 北海道公立大学法人 札幌医科大学 抗菌剤のスクリーニング方法
ES2960952T3 (es) 2018-08-09 2024-03-07 Antabio Sas Diazabiciclooctanonas como inhibidores de serina beta-lactamasas
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
CN115725607B (zh) * 2022-07-14 2023-11-28 山东第一医科大学附属省立医院(山东省立医院) 一种鼻疽诺卡菌的致病靶基因及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020121A (en) * 1995-09-29 2000-02-01 Microcide Pharmaceuticals, Inc. Inhibitors of regulatory pathways
CA2330544A1 (en) * 1998-06-12 1999-12-23 University Of Guelph A novel gene and method of treating a gram negative bacterial infection
US6846667B1 (en) * 1998-11-09 2005-01-25 Microscience, Ltd. Virulence genes and proteins, and their use
AU3584500A (en) * 1999-01-27 2000-08-18 Elitra Pharmaceuticals, Inc. Genes identified as required for proliferation in escherichia coli
FR2842210B1 (fr) * 2002-07-09 2012-12-14 Mutabilis Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique

Also Published As

Publication number Publication date
JP2006515155A (ja) 2006-05-25
AU2009201727A1 (en) 2009-05-21
EP1523572A2 (de) 2005-04-20
WO2004005535A3 (en) 2004-11-18
US20070111229A1 (en) 2007-05-17
HK1078902A1 (en) 2006-03-24
AU2003266246A1 (en) 2004-01-23
DE60320797D1 (de) 2008-06-19
US20060003393A1 (en) 2006-01-05
ES2306891T3 (es) 2008-11-16
CA2491847A1 (en) 2004-01-15
EP1523572B1 (de) 2008-05-07
FR2842210B1 (fr) 2012-12-14
DK1523572T3 (da) 2008-09-08
US20110236886A1 (en) 2011-09-29
WO2004005535A2 (en) 2004-01-15
FR2842210A1 (fr) 2004-01-16

Similar Documents

Publication Publication Date Title
Connolly et al. The host metabolite D-serine contributes to bacterial niche specificity through gene selection
Brencic et al. The GacS/GacA signal transduction system of Pseudomonas aeruginosa acts exclusively through its control over the transcription of the RsmY and RsmZ regulatory small RNAs
Xiao et al. Isolation and identification of fish pathogen Edwardsiella tarda from mariculture in China
Arciola et al. Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections
Vasudevan et al. Phenotypic and genotypic characterization of bovine mastitis isolates of Staphylococcus aureus for biofilm formation
ATE394503T1 (de) Pathogene determinanten als zielmoleküle zur entwicklung von mitteln welche bakterielle infektionen und/oder systemische verbreitung verhindern und kontrollieren können
Kröber et al. Comparative transcriptome analysis of the biocontrol strain Bacillus amyloliquefaciens FZB42 as response to biofilm formation analyzed by RNA sequencing
Slany et al. Formation of Staphylococcus aureus biofilm in the presence of sublethal concentrations of disinfectants studied via a transcriptomic analysis using transcriptome sequencing (RNA-seq)
Kokcha et al. Non-contiguous finished genome sequence and description of Brevibacterium senegalense sp. nov.
Dulla et al. Acyl-homoserine lactone-mediated cross talk among epiphytic bacteria modulates behavior of Pseudomonas syringae on leaves
Kim et al. Improved multiplex PCR primers for rapid identification of coagulase-negative staphylococci
Ostria-Hernández et al. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae
CY1116385T1 (el) Αντινοηματικη διαμορφωση της εκφρασης της απολιποπρωτεινης β
Handley et al. PerR controls oxidative stress defence and aerotolerance but not motility-associated phenotypes of Campylobacter jejuni
Savage et al. Population diversification in Staphylococcus aureus biofilms may promote dissemination and persistence
ATE480247T1 (de) Immunstimulierendes mittel enthaltend eine biomasse von methanotrophem bakterium
Atshan et al. Comparative proteomic analysis of extracellular proteins expressed by various clonal types of Staphylococcus aureus and during planktonic growth and biofilm development
Besse et al. Pseudomonas aeruginosa strains from both clinical and environmental origins readily adopt a stable small-colony-variant phenotype resulting from single mutations in c-di-GMP pathways
Hossain et al. Phylogenetic characteristics, virulence properties and antibiogram profile of motile Aeromonas spp. isolated from ornamental guppy (Poecilia reticulata)
Wang et al. Changes in diversity of cultured bacteria resistant to erythromycin and tetracycline in swine manure during simulated composting and lagoon storage
Ibarra Caballero et al. Genome sequence of Xanthomonas arboricola pv. corylina, isolated from Turkish filbert in Colorado
Perichon et al. Glycopeptide-resistant Enterococcus faecium BM4416 is a VanD-type strain with an impaired D-alanine: D-alanine ligase
Illakkiam et al. Genome sequencing of a mung bean plant growth promoting strain of P. aeruginosa with biocontrol ability
Kalai et al. Multidrug resistant staphylococci isolated from pigs with exudative epidermitis in North eastern Region of India
Donvito et al. Distribution of the synergistic haemolysin genes hld and slush with respect to agr in human staphylococci

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1523572

Country of ref document: EP

EEIH Change in the person of patent owner